Company Filing History:
Years Active: 2022
Title: Lone Pridal - Innovator in Protein Conjugates
Introduction
Lone Pridal is a notable inventor based in Greve, Denmark. He has made significant contributions to the field of protein conjugates, particularly in the development of oligomer extended insulin-Fc conjugates. His work is aimed at improving treatments for metabolic disorders.
Latest Patents
Lone Pridal holds a patent for "Oligomer extended insulin-Fc conjugates." This invention focuses on oligomer extended insulins that are covalently attached to Fc monomer polypeptides. These conjugates are designed for use in treating metabolic disorders. The patent also covers methods for producing these conjugates, novel Fc fragments, and intermediate products. Furthermore, it includes pharmaceutical compositions that utilize these conjugates for the treatment or prevention of medical conditions related to metabolic disorders.
Career Highlights
Lone Pridal is associated with Novo Nordisk A/S, a leading company in diabetes care and other chronic conditions. His work at Novo Nordisk has allowed him to contribute to innovative solutions in the healthcare sector.
Collaborations
Lone Pridal collaborates with talented professionals such as Tina Moeller Tagmose and Peter Madsen. Their combined expertise enhances the research and development efforts at Novo Nordisk.
Conclusion
Lone Pridal's innovative work in the field of protein conjugates exemplifies the importance of research in developing effective treatments for metabolic disorders. His contributions continue to impact the healthcare industry positively.